| Date | Ref. No. | Patent No. | Title |
| 11/10/2009 | E-202-2008/0 | | A Novel Treatment for Malarial Infections |
| 11/4/2009 | E-331-2007/2 | | Viral Inactivation Using Crosslinkers and Detergents |
| 11/4/2009 | E-273-2009/0 | | Simpler is Better: The Production of Young Cell Cultures from Tumor Infiltrating Lymphocytes (TIL) Yields More Effective Adoptive Cell Transfer (ACT) Immunotherapies |
| 11/4/2009 | E-201-1998/0 | 1085908 | Immunotoxin Useful for Treatment of AIDS |
| 10/29/2009 | E-337-2001/0 | 7,368,114 | A Novel Multimeric CD4 Fusion Protein for Treating HIV Infection |
| 10/21/2009 | E-116-2006/1
E-306-2006/4 | | Influenza Vaccines, Therapeutics, and Monoclonal Antibodies |
| 10/7/2009 | E-328-2001/1 | | Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth |
| 10/7/2009 | E-147-1999/0
E-147-1999/1 | 6,977,245 | Oligodeoxynucleotide and Its Use To Induce an Immune Response |
| 10/7/2009 | E-276-2007/1 | | Neutralization of Hepatitis C Virus (HCV) |
| 9/28/2009 | E-324-2004/3 | | In Vitro Model for Hepatitis C Virion Production |
| 9/18/2009 | E-281-2006/0 | | Bactericidal Peptides from Avian Leukocyte Ribonuclease A-2 |
| 9/3/2009 | E-169-2004/0
E-281-2005/0
E-318-2000/0 | | Rapid Diagnostic Applications of Phage |
| 9/3/2009 | E-012-1999/0
E-089-1998/0
E-110-1993/0
E-178-1996/0
E-179-1996/0
E-196-1997/0
E-257-2000/0 | 5,688,501
7,163,818
7,332,307 | Therapeutic Antibacterial Applications of Phage |
| 9/2/2009 | E-159-2009/0 | | Use of a Modified Adaptor Molecule LAT to Improve Immunotherapy for Cancer and Other Diseases |
| 7/29/2009 | E-205-2008/0 | | Novel Proteins from the Sand Fly Lutzomyia longipalpis are Potent Inhibitors of Complement Activity |
| 7/29/2009 | E-204-2008/0 | | Potent Anti-Coagulant Activity of a Novel Protein from the Sand Fly Lutzomyia longipalpis |
| 7/29/2009 | E-040-2004/0 | 7,504,243 | High-yield Methods of Producing Biliverdin |
| 7/14/2009 | E-291-2008/0 | | Membrane Proximal Region of HIV gp41 Anchored to the Lipid Layer of a Virus-Like Particle Vaccine |
| 7/14/2009 | E-249-2007/0 | | A Unique Infectious Hepatitis C Virus Clone, Strain HC-TN (genotype 1a) |
| 7/9/2009 | E-198-2006/0 | | Anti-H5N1 Influenza Activity of the Antiviral Protein Cyanovirin |
| 7/6/2009 | E-074-1999/2
E-117-1995/3 | 6,193,982 | Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Use for Microbicide Development |
| 7/3/2009 | E-074-1999/0
E-074-1999/1
E-074-1999/2
E-074-1999/3
E-117-1995/0
E-117-1995/1
E-117-1995/3
E-198-2006/0 | 5,821,081
5,843,882
5,962,653
5,962,668
5,998,587
6,015,876
6,193,982
6,245,737
6,420,336
6,428,790
6,586,392
6,743,577
6,780,847
6,987,096
7,048,935
7,105,169
7,339,037 | The Protein Cyanovirin Inactivates HIV and Influenza |
| 6/1/2009 | E-093-2000/0 | 6,905,822
7,547,519 | Method of Diagnosing Multidrug Resistant Tuberculosis |
| 6/1/2009 | E-114-2009/0 | | Axenically-Produced Coxiella burnetii and Methods for Producing Axenic Coxiella burnetii |
| 5/28/2009 | E-043-2009/0 | | T Cells Attacking Cancer: T Cell Receptors that Recognize the Tyrosinase Tumor Antigen |
| 5/27/2009 | E-297-2006/0 | | CCR5-Specific Human Monoclonal Antibodies |
| 5/15/2009 | E-325-2008/0 | | Mobilizing the Body to Fight Cancer: T Cell Receptors Specific for the Tumor Antigen Survivin |
| 5/11/2009 | E-352-2003/0 | | Immunogenic West Nile Virus-Like Particles |
| 5/4/2009 | E-255-2000/0 | 7,435,801 | Therapeutic Methods Based on In Vivo Modulation of the Production of Interferon gamma |
| 5/4/2009 | E-267-2008/0 | | Substituted Triazine and Purine Compounds for the Treatment of Chagas Disease and African Trypanosomiasis |
| 5/4/2009 | E-303-2008/0 | | Insect Salivary Proteins as Potent Adjuvants for Enhancing Immune Responses |
| 3/30/2009 | E-146-2008/1 | | Adoptive Immunotherapy for Reestablishing HIV-specific Cytotoxic T-cell (CD8 T-cell) Function in HIV and AIDS Patients and Methods for Assessing the Reestablishment of CD8 T-cell Function |
| 3/23/2009 | E-161-2008/0 | | Anti-Hepatitis C Virus Activity of the Protein Scytovirin (SVN) |
| 3/23/2009 | E-304-2008/0 | | M2e Peptide Vaccine Against Influenza Virus |
| 3/23/2009 | E-162-2008/0 | | Treatment of Schistosomiasis Using Substituted Oxadiazole 2-Oxides |
| 3/11/2009 | E-078-2000/1 | 7,521,063 | Compounds Used to Improve Human Immune Responses in Diseases such as Allergies, Infections, and Cancer |
| 2/17/2009 | E-173-2008/0 | | Compositions and Methods for Vaccine and Virus Production |
| 2/2/2009 | E-142-2008/0 | | Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use |
| 1/9/2009 | E-182-2008/0 | | Method of Treating Pneumoconiosis with Oligodeoxynucleotides |
| 1/9/2009 | E-278-2007/0 | | Attenuated Salmonella as a Delivery System for siRNA-Based Tumor Therapy |
| 12/1/2008 | E-004-2004/2 | 7,025,961 | Anti-Plasmodium Compositions and Methods of Use |
| 11/1/2008 | E-211-2008/0 | | Fully Human Anti-Human Monoclonal Antibody Helpful in Developing Therapies Against Autoimmune and Infectious Diseases and Cancer |
| 11/1/2008 | E-250-2007/0 | | Induced Internalization of Surface Receptors |
| 10/1/2008 | E-301-2003/0 | | A Method with Increased Yield for Production of Polysaccharide-Protein Conjugate Vaccines Using Hydrazide Chemistry |
| 10/1/2008 | E-204-2007/0 | | Methods of Glycosylation and Bioconjugation |
| 10/1/2008 | E-145-2004/3 | | Monoclonal Antibodies Against Orthopoxviruses |
| 10/1/2008 | E-159-2007/3 | | Monoclonal Antibodies Against Dengue and Other Viruses With Deletion in Fc Region |
| 10/1/2008 | E-279-2007/0 | | Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use |
| 10/1/2008 | E-280-2007/0 | | Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use |
| 10/1/2008 | E-066-2003/5 | | Monoclonal Antibodies That Bind or Neutralize Dengue Virus |
| 10/1/2008 | E-152-2004/0 | | Use of Suppressive Oligonucleotides to Treat Uveitis |
| 10/1/2008 | E-183-2002/0 | | Method of Treating Infectious and Inflammatory Lung Disease with Suppressive Oligonucleotides |
| 10/1/2008 | E-153-2002/0 | | Method of Treating and Preventing Infections in Immunocompromised Subjects with Immunostimulatory CpG Oligonucleotides |
| 10/1/2008 | E-089-2002/1 | 7,517,531 | Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4 |
| 10/1/2008 | E-230-2002/2 | 7,482,133 | Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use |
| 9/1/2008 | E-032-1993/1 | 5,762,905
6,685,942 | Human Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus and Human Neutralizing Antibodies to Respiratory Syncytial Virus |
| 9/1/2008 | E-149-2006/2 | | Compositions and Methods for Increasing Recombinant Protein Yields through the Modification of Cellular Properties |
| 9/1/2008 | E-123-2007/0
E-146-2004/0 | | Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF) |
| 9/1/2008 | E-001-1996/0 | 7,488,477 | Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus |
| 9/1/2008 | E-236-2007/3 | | Immunogenic Peptides Against Influenza Virus |
| 9/1/2008 | E-268-2002/0 | 7,261,900 | Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines |
| 9/1/2008 | E-178-1999/0
E-178-1999/1
E-178-1999/2 | 00810119.1
10-0905450
1287152
784216 | Human-Bovine Chimeric Respiratory Syncytial Virus (RSV) Vaccines |
| 9/1/2008 | E-032-2008/0 | | Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax |
| 9/1/2008 | E-016-2008/0 | | Modified Sugar Substrates and Methods of Use |
| 9/1/2008 | E-343-2002/0 | | gammaPGA Conjugates for Eliciting Immune Responses Directed Against Bacillus anthracis and Other Bacilli |
| 8/1/2008 | E-141-2003/0 | | Monoclonal Antibodies to HIV-1 Vpr |
| 8/1/2008 | E-159-2008/0 | | Polyamine Compounds That Bind Tar RNA of HIV and Methods of Treating Viral Disorders |
| 8/1/2008 | E-072-2008/0 | | HIV Immunogen and Method of Making and Using Same |
| 8/1/2008 | E-043-2008/0 | | Cross-Reactive Neutralizing Human Domain Antibody Against HIV-1 |
| 7/1/2008 | E-095-2008/0 | | A Prophylactic and Therapeutic for Preventing and Treating Tularemia by Rapid Activation of Host Cells and Antigen Recognition |
| 5/1/2008 | E-012-2008/0 | | C4'-Substituted-2-Deoxyadenosine Analogs and Methods of Treating HIV |
| 5/1/2008 | E-206-1995/3 | 6,320,022
7,101,548 | Treatment and Diagnosis of Cancer, Diabetes and other Disorders Using Adrenomedullin Peptides and Antibodies |
| 4/1/2008 | E-003-2007/0 | | Engineered Human Antibody Constant Domains (Nanoantibodies) as Scaffolds for Binders |
| 4/1/2008 | E-036-2005/0 | | Identification of a Cell-Surface Co-Receptor that Mediates the Uptake and Immunostimulatory Activity of “D” Type CpG Oligonucleotides |
| 3/1/2008 | E-316-2003/0 | | Immunoglobulins with Potent and Broad Antiviral (HIV) Activity Based on scFv Joined by Flexible Linker to Fc |
| 3/1/2008 | E-247-2002/1 | | Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis) |
| 2/1/2008 | E-116-2004/0 | | Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutics Agents |
| 2/1/2008 | E-055-2007/3 | | Inhibiting HIV Infection Using Integrin Antagonists |
| 2/1/2008 | E-208-2007/0 | | Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers |
| 11/1/2007 | E-076-1997/1 | | Novel Non-Nucleoside Agents for the Inhibition of HIV Reverse Transcriptase for the Treatment of HIV-1 |
| 10/1/2007 | E-104-2004/0
E-104-2004/1 | | Method for Inducing T-Cell Proliferation |
| 10/1/2007 | E-308-2005/0 | | Discovery of Tropolone Inhibitors of HIV-1 Integrase that can be Used for the Treatment of Retroviral Infection, Including AIDS |
| 10/1/2007 | E-264-2006/0 | | Integrase Inhibitors for the Treatment of Retroviral Infection Including Human Immunodeficiency Virus-1 |
| 10/1/2007 | E-237-2007/0 | | HIV-1 Integrase Inhibitors for the Treatment of Retroviral Infections |
| 10/1/2007 | E-039-2002/0 | | Potent HIV-1 Entry Inhibitors and Immunogens |
| 10/1/2007 | E-187-2003/0 | | Quinoline Inhibitors of Retroviral Integrase |
| 9/1/2007 | E-137-2005/0 | | Methods and Compositions for Treating FUS1 Related Disorders |
| 8/1/2007 | E-013-2006/1 | | Antiviral Compounds with Broad Neutralization Capabilities |
| 8/1/2007 | E-179-2007/0 | | Methods for Prevention and Treatment of Polyomavirus Infection or Reactivation (E-179-2007) |
| 8/1/2007 | E-068-1998/0 | 6,685,933
7,235,232 | Interferon Alpha Hybrids |
| 7/1/2007 | E-151-2006/0
E-151-2006/1 | | Viral Entry or Replication Inhibitors |
| 6/1/2007 | E-144-2004/0 | | Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
| 6/1/2007 | E-090-1996/0 | 7,151,087
7,374,872 | CC Chemokine Receptor 5 DNA, New Animal Models and Therapeutic Agents for HIV Infection |
| 6/1/2007 | E-274-2000/0 | 7,527,797 | Vibrio cholerae O139 Conjugate Vaccines |
| 4/1/2007 | E-121-2002/0 | 7,572,828 | Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid |
| 2/1/2007 | E-130-2001/0 | 7,223,844
7,378,093 | Broadly Cross-Reactive Neutralizing Antibodies against Human Immunodeficiency Virus Selected by ENV-CD4-CO-Receptor Complexes |
| 12/1/2006 | E-252-2001/0 | | HIV Entry Inhibitor |
| 11/1/2006 | E-200-1998/0 | 7,470,506 | Methods for Treating Drug-Resistant HIV-1 Infection |
| 9/1/2006 | E-017-2006/0 | | Organic Thiophosphate Antiretroviral Agents |
| 8/1/2006 | E-166-2006/0 | | A Novel Small Protein Antibiotic |
| 8/1/2006 | E-180-2006/0 | | Neutralizing Monoclonal Antibodies to Botulinum neurotoxin A |
| 8/1/2006 | E-329-2000/0 | 7,528,274 | Novel Acylthiol Compositions and Methods of Making and Using Them |
| 7/1/2006 | E-017-2004/0 | | Methods and Compositions Related to GHS-R Antagonist |
| 5/1/2006 | E-055-1999/0 | 6,680,176 | Identification of Candidate Ligands which Modulate Antigen Presenting Cells |
| 5/1/2006 | E-265-2003/0 | | Methods for Inhibiting HIV and Other Viral Infections by Modulating Ceramide Metabolism |
| 5/1/2006 | E-114-2003/0 | | Methods and Compositions for the Inhibition of HIV-1 Replication |
| 2/1/2006 | E-072-1992/0 | 5,976,541 | Potent Peptide for Stimulation of Cytotoxic T Lymphocyte Specific for the HIV-1 Envelope |
| 2/1/2006 | E-025-2006/0 | | Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use |
| 2/1/2006 | E-152-1991/1 | 5,932,218
6,214,347
6,294,322 | Multideterminant Peptides That Elicit Helper T-Lymphocyte Cytotoxic T-Lymphocyte and Neutralizing Antibody Responses Against HIV-1 |
| 2/1/2006 | E-174-1993/1
E-174-1993/2 | 0782632
6,001,555
6,989,263 | The CCHC Zinc Fingers of the Retroviral Nucleocapsid Protein Comprises a New Target Useful in Identification and Evaluation of Anti-HIV Therapeutics |
| 2/1/2006 | E-249-2004/1
E-308-2000/0 | | Therapeutic HIV Vaccine Vectors for Individuals Receiving Antiretroviral Therapy |
| 12/1/2005 | E-253-2005/0 | | Methods and Compositions for the Inhibition of SARS-CoV Replication Propagation and Transmission |
| 12/1/2005 | E-142-2005/0 | | A Single Ribozyme to Catalyze both Trimming and Transacting Catalysis - Potential Therapeutic for HPV Infection and Cervical Cancer |
| 12/1/2005 | E-133-2005/0 | | Genomic Nucleic Acid Sequence for Cyanovirin-N and Signal Peptide Thereof |
| 11/1/2005 | E-104-2005/1 | | Furin Inhibitors and Alpha-Defensin for Preventing Papilloma Virus Infection |
| 11/1/2005 | E-051-2005/0 | | Identification of a Fusion/Entry Receptor for Human Herpesvirus-8 |
| 8/1/2005 | E-180-2005/0 | | Scytovirin Domain 1 (SD1) Related Polypeptide |
| 8/1/2005 | E-137-2003/1 | | Vaccines and Methods of Treating Drug-Resistant HIV-1 and Hepatitis B Viruses |
| 8/1/2005 | E-155-2005/0
E-155-2005/1
E-155-2005/2
E-155-2005/3 | | Immunogenic Peptides From Human Papillomavirus Type 16 E2 |
| 8/1/2005 | E-047-2005/0 | | North-2'-Deoxy-Methanocarbathymidines as Antiviral Agents Against Poxviruses |
| 8/1/2005 | E-046-2005/0 | | A Novel Interleukin-12 (IL-12) Inducing Protein Isolated from Toxoplasma gondii Inflammatory Profilin (TGIP) |
| 8/1/2005 | E-302-2004/0 | | A32 Monoclonal Antibody Fusion Protein for Use as HIV Inhibitors and Vaccines |
| 8/1/2005 | E-257-2000/0 | 7,163,818 | Bacteriophage Having Multiple Host Range |
| 8/1/2005 | E-318-2000/0 | | Method for Determining Sensitivity to a Bacteriophage |
| 6/1/2005 | E-043-2005/0 | | Cell Culture System for Efficient Expression of Self-Replicating Norwalk Virus |
| 6/1/2005 | E-121-2004/0 | | A New Antiviral Pathway that is Responsible for Viral Clearance: Modulation of ADAR1 Activities Enhance Antiviral Therapies and Virus Infection of Tissue Culture Systems |
| 6/1/2005 | E-050-1998/0 | 6,153,421
7,201,911 | Cloned Genomes Of Infectious Hepatitis C Virus And Uses Thereof |
| 6/1/2005 | E-271-2003/0
E-271-2003/1 | | Epitopes of Ebola Virus Glycoproteins Useful for Vaccine Development |
| 5/1/2005 | E-330-2004/0 | 7,408,075 | Synthesis of Phosphocholine Ester Derivatives and Conjugates Thereof |
| 5/1/2005 | E-355-2001/2 | 7,494,813 | VAC-BAC Shuttle Vector System |
| 5/1/2005 | E-279-2004/0 | | Treatment of Human Viral Infections (Resveratrol) |
| 5/1/2005 | E-280-2004/0 | | Treatment of Human Viral Infections (Proteosome Inhibitors) |
| 5/1/2005 | E-281-2004/0 | | Treatment of Human Viral Infections (Imatinib) |
| 5/1/2005 | E-282-2004/0 | | Treatment of Human Viral Infections (Farnesyl Transferase Inhibitors) |
| 4/1/2005 | E-176-2003/0 | | Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria |
| 4/1/2005 | E-150-2001/1 | 7,175,838 | Use of a Promoter of T-cell Expansion and an Inducer of CD40 Stimulation in the Treatment or Prevention of a Pathologic State |
| 4/1/2005 | E-263-2002/0 | | Peptide Inhibitors of Yersinia Phosphatase (YopH) as Potential Treatments Against Plague |
| 4/1/2005 | E-023-2003/0 | 7,303,754 | MVA Expressing Modified HIV envelope, gag, and pol Genes |
| 3/1/2005 | E-251-2004/0 | | Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies |
| 3/1/2005 | E-215-2004/0 | | CpG Oligonucleotide Prodrugs |
| 3/1/2005 | E-076-2004/0 | | An Epitope-Enhancement of Human CD4 HIV Epitope |
| 3/1/2005 | E-160-2002/0 | 7,541,139 | Tryptophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins |
| 1/1/2005 | E-191-2003/1 | | Eosinophil-Derived Neurotoxin, an Antimicrobial Protein with Ribonuclease Activity, is an Immunostimulant |
| 12/1/2004 | E-004-2005/0
E-004-2005/4 | | Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 12/1/2004 | E-299-2004/0 | | Vaccines Against Crimean-Congo Hemorrhagic Fever |
| 11/1/2004 | E-233-2004/0
E-233-2004/1 | | Anti-HIV Peptide Secreting Bacteria: Therapeutics and Methods of Use |
| 10/1/2004 | E-049-2004/0 | 7,303,751 | Anti-Plasmodium Compositions and Methods of Use |
| 10/1/2004 | E-256-2004/0 | | Inhibitors of HIV Ribonuclease H Antiviral Properties |
| 10/1/2004 | E-272-2004/0 | 7,510,715 | Protozoan Derived Antagonist of CCR5 |
| 8/1/2004 | E-106-2003/0 | | Griffithsin, Glycosylation-Resistant Griffithsin, and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using |
| 6/1/2004 | E-228-2003/1
E-228-2003/2 | | Soluble SARS Coronavirus Spike Protein (S Protein) |
| 6/1/2004 | E-150-2004/0 | | A Peptide that Elicits Neutralizing Antibodies Targeting the HIV Co-Receptor CCR5 |
| 6/1/2004 | E-335-2003/0
E-335-2003/1 | | Mechanisms for Improving the Breadth of the Immune Response to Diverse Strains and Clades of HIV |
| 4/1/2004 | E-073-2004/0 | | Reduction of HIV-1 Replication by a Mutant Apolipoprotein B mRNA Editing Enzyme-Catalytic Polypeptide-like 3G (APOBEC3G) |
| 4/1/2004 | E-326-2002/0
E-326-2002/2 | | Triplex Hairpin Ribozyme |
| 4/1/2004 | E-068-2004/0 | | MVL, an Antiviral Protein from a Cyanobacterium |
| 3/1/2004 | E-008-1996/0 | | C-C Chemokines That Inhibit Retrovirus Infection |
| 2/1/2004 | E-286-2002/0
E-286-2002/1
E-286-2002/2 | | Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis |
| 1/1/2004 | E-324-2003/0 | | Streptococcus Lipoprotein Antigens |
| 1/1/2004 | E-189-1998/0 | | Inhibitors of Formation of Protease Resistant Prion Protein |
| 12/1/2003 | E-191-2001/0 | | gp64 Pseudotyped Vectors and Uses Thereof |
| 12/1/2003 | E-019-2004/0 | | Construction of Replication-Competent Chimeric Simian Immunodeficiency Virus (SIV) Human Immunodeficiency Virus Type 1 (HIV-1) Viruses that Replicate Using HIV-1 Reverse Transcriptase and Integrase (IN): A Model System for Development and Testing of Antiviral Agents for the Treatment of HIV-1 Infection |
| 12/1/2003 | E-276-2003/0 | | HIV-Dependent Expression Vector |
| 12/1/2003 | E-022-2003/0 | | Discovery of Novel Inhibitors of HIV-1 Integrase and/or RNase H That Can Be Used for the Treatment of Retroviral Infection Including AIDS |
| 11/1/2003 | E-090-1994/0
E-200-1994/0
E-200-1994/2
E-201-1994/0
E-201-1994/1 | 5,571,919
5,578,729
5,639,761
5,786,482
5,789,594
6,627,641 | Novel Antimalarial Compounds, Methods of Synthesis Thereof, Pharmaceutical Compositions Comprising Same, and Methods of Using Same for Treatment and Prevention of Malaria |
| 11/1/2003 | E-086-1999/0 | 6,875,855
7,332,167 | Molecular Diagnosis of Disseminated Candida albicans Infection Using Hemoglobin-Response Gene |
| 11/1/2003 | E-145-1987/0
E-145-1987/1
E-145-1987/2
E-217-1988/0 | 5,221,732
5,567,681
5,643,876 | Antimicrobial Magainin Peptides |
| 11/1/2003 | E-072-2001/0 | 7,119,193 | Identification of New Small RNAs and ORFs |
| 11/1/2003 | E-224-2003/0 | | Inhibition of Retrovirus Gene Expression by PSF |
| 11/1/2003 | E-285-2002/0 | 7,485,306 | Lutozmyia longipalpis Polypeptides and Methods of Use |
| 9/1/2003 | E-150-1994/0 | 5,622,861 | Hepatitis A Virus Receptor And Methods Of Use |
| 9/1/2003 | E-145-2002/0 | | Sigma-2 Receptor Agonists Inhibit HIV Infection and Replication in Lymphocytes |
| 9/1/2003 | E-224-2002/0 | | Novel Anti-Tumor and Anti-Fungal Compounds Isolated from Plants of the Genus Aniba |
| 8/1/2003 | E-225-2003/0 | | Protection Against Vertical Transmission of Pathogenic Infections |
| 8/1/2003 | E-327-2002/0 | | Inhibition of HIV-1 Replication by the Ribonuclease, Recombinant Angiogenin |
| 8/1/2003 | E-063-2003/0 | | Rapamycin Resistant T Cells and Therapeutic Uses Thereof |
| 7/1/2003 | E-190-2000/0 | | Methods and Compositions for Inhibiting HIV-Coreceptor Interactions |
| 7/1/2003 | E-173-2001/0 | | HTLV-1 p30II and p12I Proteins as Therapeutic Targets in HTLV-1 Infected Individuals |
| 5/1/2003 | E-097-2003/0 | | Triggering Receptors Expressed in Myeloid Cells (TREM) Like Transcript (TLT-1), A Novel Inhibitory Receptor of Platelets and Uses Therefore |
| 5/1/2003 | E-240-2002/0 | | HTLV-1 Cell Binding and Inhibition |
| 4/1/2003 | E-017-2002/0 | 7,491,798 | Scytovirins and Related Conjugates, Antibodies, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Using Scytovirin |
| 2/1/2003 | E-008-2003/0 | | Scavenger Receptor BI Targeting for the Treatment of Infection, Sepsis and Inflammation |
| 1/1/2003 | E-144-2002/0
E-144-2002/1 | 7,566,451 | vel Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Selected from Fab Phage Display Libraries Using a Novel Strategy Based on Alternative Antigen Panning
and
Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Single-Chain Antibodies Derived from X5 by DNA Shuffling and Alternating Antigen Panning |
| 12/1/2002 | E-090-2002/0 | | Assays for Assembly of Ebola Virus Pseudoparticles Relevant to Antiviral Therapy and Vaccines |
| 11/1/2002 | E-317-2001/0 | | Discovery of Novel Inhibitors of HIV-1 Integrase That Can Be Used for the Treatment of Retroviral Infection Including AIDS |
| 11/1/2002 | E-080-2002/0 | 7,511,015 | Modified Defensins and Their Use |
| 10/1/2002 | E-356-2001/0 | 7,282,205 | Four Chimpanzee Monoclonal Antibodies that Neutralize Hepatitis A Virus |
| 8/1/2002 | E-096-2002/0 | 7,276,227 | An Obligate Domain-Swapped Dimer of Cyanovirin with Enhanced Anti-Viral Activity |
| 8/1/2002 | E-321-2001/0 | 7,109,245 | Methods and Compositions for Antagonizing Septic Shock |
| 4/1/2002 | E-099-2001/0 | | Mitochondrial Topoisomerase I |
| 3/1/2002 | E-328-2001/0 | 7,615,227 | Use of CpG Oligodeoxynucleotides to Encourage Angiogenesis |
| 2/1/2002 | E-282-2001/0 | | N-Formyl Peptide Receptor Mediation of Platelet Chemotaxis Toward Injured Cells and Activation of Immune Response |
| 2/1/2002 | E-214-2001/0 | 7,354,909 | Novel Method for Rapidly Generating Mature Dendritic Cells from Peripheral Blood Monocytes and Myeloid Precursors |
| 2/1/2002 | E-215-2001/0 | | Use of Sterically Stabilized Cationic Liposomes to Efficiently Deliver CpG Oligonucleotides in vivo |
| 2/1/2002 | E-218-2001/0 | 7,514,414 | Identification of DNA Sequence Motifs that Suppress the Immune Response to CpG DNA |
| 2/1/2002 | E-122-2001/0 | 7,388,089 | Anti-Arthropod Vector Vaccines, Methods of Selecting, and Uses Thereof |
| 2/1/2002 | E-242-2001/0 | | Strategies to Destabilize the Active HIV-1 Protease Dimer Resulting in Stable Monomer Formation |
| 1/1/2002 | E-126-2000/0 | 6,673,905
7,211,445 | A Method for Bioconjugation Using Diels-Alder Cycloaddition |
| 1/1/2002 | E-285-2000/0 | | LL-37 is an Immunostimulant |
| 1/1/2002 | E-089-2001/0 | | Suppression of CCR5- but not CXCR4-Tropic HIV-1 Replication in Lymphoid Tissue by Human Herpes Virus 6 |
| 1/1/2002 | E-126-2001/0 | 7,189,513
7,507,538 | Human Papilloma Virus Immunoreactive Peptides |
| 11/1/2001 | E-051-1990/0
E-081-1987/1 | 5,376,642 | Method of Treating HIV with 2',3'-Dideoxyinosine (ddI; didanosine) |
| 9/1/2001 | E-179-2001/0 | | Identification of a Cell-surface Receptor for Papillomaviruses |
| 6/1/2001 | E-249-2000/0 | 7,009,050 | 5-Substituted Derivatives of Conformationally Locked Nucleoside Analogues |
| 4/1/2001 | E-188-2000/0 | | Method of Preparing a Production Intermediate for HIV Protease Inhibitors |
| 4/1/2001 | E-276-2000/0 | | A Method of Inhibiting Viral Replication Targeting the Nucleocapsid Protein |
| 2/1/2001 | E-082-1996/0 | | Simian-Human HAV Chimeras Encoding a Hepatitis A Virus Having a Chimeric 2C Protein |
| 12/1/2000 | E-208-2000/0 | 7,078,508 | Ixodes scapularis Tissue Factor Pathway Inhibitor |
| 12/1/2000 | E-207-2000/0 | 7,153,947 | Ixodes Salivary Anticomplement Protein |
| 9/1/2000 | E-061-1999/0 | | Polypeptides Comprising IL-6 Ligand Binding Receptor Domains and Related Nucleic Acids, Antibodies, Compositions and Methods |
| 7/1/2000 | E-245-1999/0 | 7,304,127 | Polypeptides that Bind HIV gp120 and Related Nucleic Acids, Antibodies, Compositions, and Methods of Use |
| 7/1/2000 | E-068-2000/0 | | Molecules That Influence Pathogen Resistance |
| 4/1/2000 | E-203-1999/0 | 6,855,323 | Identification of the Domain of Plasmodium falciparum Erythrocyte Membrane Protein (PfEMP1) that Mediates Adhesion to Chondroitin Sulfate A |
| 10/1/1999 | E-210-1998/0 | 6,613,764
7,132,420 | Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods |
| 10/1/1999 | E-220-1994/0 | 5,728,718
5,925,780
6,066,656 | 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane Isosteres Comprising Benzamide, Sulfonamide and Anthranilamide Subunits and Methods of Using |
| 9/1/1999 | E-107-1996/0 | 6,316,190 | Oligonucleotides Which Specifically Bind Retroviral Nucleocapsid Proteins |
| 9/1/1999 | E-216-1994/0 | 6,057,346 | Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers |
| 9/1/1999 | E-059-1996/0 | 6,686,333 | Inhibition of HIV Replication Using Soluble Tat Peptide Analogs |
| 6/1/1999 | E-092-1988/0 | | Immunologically Active Peptides From The HIV Envelope Protein Eliciting Both Antibody And T Cell Responses |
| 4/1/1999 | E-138-1995/0 | 5,872,210 | Transframe Peptide Inhibitor Of Viral Protease |
| 2/1/1999 | E-217-1998/0 | 6,719,978
7,371,572
7,479,280 | Chimeric Virus-Like Particles For The Induction Of Autoantibodies |
| 1/1/1999 | E-099-1990/0 | 5,474,935 | Adeno-Associated Virus (AAV)-Based Eucaryotic Vectors |
| 10/1/1998 | E-099-1991/1 | 5,455,251
5,654,432 | Michellamine Antiviral Agents, Compositions, And Treatment Methods |
| 10/1/1998 | E-090-1994/0 | 5,639,761
6,627,641 | Antimalarial Napthylisoquinoline Alkaloids And Pharmaceutical Compositions And Medicinal Uses Thereof |
| 10/1/1998 | E-096-1994/0 | 5,409,938 | Antimalarial Korupensamines And Pharmaceutical Compositions And Medical Uses Thereof |
| 10/1/1998 | E-201-1994/0 | 5,571,919
5,789,594 | Dimeric Naphthylisoquinoline Alkaloids And Synthesis Methods Thereof |
| 10/1/1998 | E-200-1994/0 | | Monomeric Naphthylisoquinoline Alkaloids And Synthesis Methods Thereof |
| 10/1/1998 | E-201-1994/1 | 5,578,729
5,786,482 | Dimeric Arylisoquinoline Alkaloids And Synthesis Methods Thereof |
| 10/1/1998 | E-200-1994/2 | | Monomeric And Dimeric Arylisoquinoline Alkaloids And Derivatives Thereof |
| 9/1/1998 | E-039-1996/0 | 6,046,228 | Anti-Viral Pharmaceutical Compositions Containing 1,2-Dithiane Compounds And Methods Of Using Thereof |
| 9/1/1998 | E-290-1997/0 | 7,105,488 | G-Protein Coupled Receptor Antagonists |
| 5/1/1998 | E-202-1997/0 | | Methods For Treating Parasitic Infection Using Thiopeptides |
| 3/1/1998 | E-209-1997/0 | 6,600,030 | Delayed Progression To AIDS By A Missense Allele Of The CCR2 Gene |
| 3/1/1998 | E-222-1997/0 | | Functional Promoter For CCR5 |
| 3/1/1998 | E-230-1997/0 | | Human Papilloma Virus Inhibition By Antisense Oligonucleotides |
| 3/1/1998 | E-087-1997/0 | | STRL33, A Human Fusion Accessory Factor Associated With HIV Infection |
| 10/1/1997 | E-120-1993/0 | | Diagnostic Reagents And Vaccines For Multiple Genotypes Of Hepatitis C Virus |
| 5/1/1997 | E-019-1993/0 | 5,449,608 | Parvovirus B19 Receptor And Parvovirus B19 Detection |
| 11/1/1996 | E-017-1996/1 | 6,197,578 | Cells Expressing Both Human CD4 And A Human Fusion Accessory Factor Associated With HIV Infection |
| 10/1/1996 | E-061-1992/0 | 5,317,009 | Anti-HIV Proteins GAP 31, DAP 30 And DAP 32 And Therapeutic Uses Thereof |
| 10/1/1996 | E-190-1990/0 | 5,484,889 | Plant Protein Useful For Treating Tumors And HIV Infection |
| 10/1/1996 | E-085-1992/0 | 5,532,214 | An Anti-HIV Protein, TAP 29, From Trichosanthes, DNA Coding Therefor And Therapeutic Uses Thereof |
| 8/1/1996 | E-226-1993/0 | 5,677,275
5,877,148 | Treatment Of Cancer With Human Chorionic Gonadotropin |
| 8/1/1996 | E-029-1996/0 | 5,763,464 | Novel Retroviral Agents Containing Anthranilamide, Substituted Benzamide And Other Subunits, And Methods Of Using Same |
| 4/1/1996 | E-209-1993/0 | 5,439,899 | Cosalane And Related Compounds Having Activity Against AIDS And AIDS-Related Infections |
| 4/1/1996 | E-169-1993/0 | 5,990,088 | Method For Treatment Of Kaposi's Sarcoma (KS) By Antisense Oligonucleotides |
| 2/1/1996 | E-038-1995/0 | 5,681,832 | Amido Substituted Stilbenes And Related Compounds With In Vitro Anti-HIV Activity |
| 5/1/1995 | E-134-1994/0 | | Hepatitis C Virus Core Peptide For Stimulation Of Cytotoxic T Lymphocytes |
| 11/1/1994 | E-325-1983/2 | 5,516,630 | Production Of Complementary DNA Representing Hepatitis A Viral Sequences By Recombinant DNA Methods And Uses Therefor |
| 11/1/1994 | E-023-1994/0 | 5,498,719 | Diastereoselective Process Leading To A Key Intermediate For The Preparation Of Fluorinated Reverse Transcriptase Inhibitors |
| 11/1/1994 | E-095-1994/0 | 5,610,198 | Novel Anti-Mycobacterial Compositions and Their Use for the Treatment of Tuberculosis and Related Diseases |
| 11/1/1994 | E-037-1993/0 | 5,386,021
5,514,600 | Mammalian Guanine Nucleotide-Binding Protein with an ADP-Ribosylation Factor Domain (ARD1) |
| 11/1/1994 | E-076-1992/0 | | Clones Encoding Mammalian ADP-Ribosylarginine Hydrolases |
| 1/1/1991 | E-493-1985/0
E-493-1985/1 | | 3-Deazaneplanocin, Intermediates for It, and Antiviral Composition and Method of Treatment Using It |